Abby Douglas
Impact in
- Pharmacology top 2%
- Drug-Induced Adverse Reactions
Papers in
- Pharmacology 14
- Drug-Induced Adverse Reactions 13
-
- Antifungal resistance and susceptibility 7
- Antimicrobial Resistance in Staphylococcus 3
- Co-authors
- Monica A. Slavin (23 shared papers)Jason A. Trubiano (14 shared papers)Elizabeth J. Phillips (7 shared papers)Natasha E. Holmes (11 shared papers)Kyra Chua (10 shared papers)Sara Vogrin (9 shared papers)Olivia Smibert (5 shared papers)S.C.-A. Chen (1 shared paper)
- Journals
- Open Forum Infectious Diseases (5 papers)The Journal of Allergy and Clinical Immunology In Practice (4 papers)Current Opinion in Infectious Diseases (4 papers)Clinical Infectious Diseases (3 papers)Journal of Antimicrobial Chemotherapy (3 papers)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Abby Douglas
38 papers receiving 989 citations
Abby Douglas's Hit Papers
Peers
Comparison fields: 5 of 83
- Pharmacology 489
- Applied Microbiology and Biotechnology 44
- Immunology and Allergy 96
- Infectious Diseases 278
- Toxicology 52
Countries citing papers authored by Abby Douglas
This map shows the geographic impact of Abby Douglas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abby Douglas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abby Douglas more than expected).
Fields of papers citing papers by Abby Douglas
This network shows the impact of papers produced by Abby Douglas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abby Douglas. The network helps show where Abby Douglas may publish in the future.
Co-authors
The 25 scholars most cited alongside Abby Douglas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Development and Validation of a Penicillin Allergy Clinical Decision Rule Hit paper breakdown → | 2020 | 211 |
| 2 | 2021 | 105 | |
| 3 | 2020 | 103 | |
| 4 | 2016 | 78 | |
| 5 | 2018 | 77 | |
| 6 | 2018 | 67 | |
| 7 | 2018 | 53 | |
| 8 | 2021 | 36 | |
| 9 | 2020 | 25 | |
| 10 | 2019 | 24 | |
| 11 | 2010 | 24 | |
| 12 | 2020 | 23 | |
| 13 | 2023 | 21 | |
| 14 | 2020 | 15 | |
| 15 | 2021 | 15 | |
| 16 | 2017 | 14 | |
| 17 | 2017 | 14 | |
| 18 | 2019 | 11 | |
| 19 | 2023 | 11 | |
| 20 | 2020 | 10 |
About Abby Douglas
Abby Douglas is a scholar working on Pharmacology, Infectious Diseases, Oncology, Epidemiology and Dermatology, having authored 40 papers that have together received 1000 indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (13 papers), Neutropenia and Cancer Infections (9 papers), Antifungal resistance and susceptibility (7 papers), Fungal Infections and Studies (6 papers), Contact Dermatitis and Allergies (4 papers), Pharmacovigilance and Adverse Drug Reactions (4 papers), Urticaria and Related Conditions (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). The work is most often cited by research in Pharmacology (489 citations), Applied Microbiology and Biotechnology (44 citations), Immunology and Allergy (96 citations), Infectious Diseases (278 citations) and Toxicology (52 citations). Abby Douglas has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Monica A. Slavin, Jason A. Trubiano, Elizabeth J. Phillips, Natasha E. Holmes, Kyra Chua, Sara Vogrin, Olivia Smibert, S.C.-A. Chen, Karin Thursky and Misha Devchand. Their work appears in journals such as Open Forum Infectious Diseases, The Journal of Allergy and Clinical Immunology In Practice, Current Opinion in Infectious Diseases, Clinical Infectious Diseases and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.